메뉴 건너뛰기




Volumn 51, Issue 10, 2015, Pages e49-e52

First series of patients with XDR and pre-XDR TB treated with regimens that included meropenen-clavulanate in Argentina;Primera serie de pacientes con TB-XDR y pre-XDR tratados con esquemas que incluyeron meropenem-clavulanato en Argentina

Author keywords

Carbapenems; Clavulanate; Meropenem; Tuberculosis; XDR TB

Indexed keywords

AMINOSALICYLIC ACID; BEDAQUILINE; CAPREOMYCIN; CLAVULANATE PLUS MEROPENEM; CLAVULANIC ACID; CLOFAZIMINE; ISONIAZID; LINEZOLID; MEROPENEM; MOXIFLOXACIN; UNCLASSIFIED DRUG; THIENAMYCIN DERIVATIVE; TUBERCULOSTATIC AGENT; CLAVULANIC ACID PLUS MEROPENEM;

EID: 84942990325     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2015.07.003     Document Type: Article
Times cited : (27)

References (6)
  • 1
    • 84942997431 scopus 로고    scopus 로고
    • Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2014.11
    • World Health Organization (WHO). Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2014.11.
  • 2
    • 84942997432 scopus 로고    scopus 로고
    • Global Tuberculosis Report 2014. WHO/HTM/TB/2014.08
    • WHO. Global Tuberculosis Report 2014. WHO/HTM/TB/2014.08.
  • 4
    • 84858638496 scopus 로고    scopus 로고
    • Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis
    • Payen M.C., de Wit S., Martín C., Sergysels R., Muylle I., van Laethem Y., et al. Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis. Int J Tuberc Lung Dis 2012, 16:558-560.
    • (2012) Int J Tuberc Lung Dis , vol.16 , pp. 558-560
    • Payen, M.C.1    de Wit, S.2    Martín, C.3    Sergysels, R.4    Muylle, I.5    van Laethem, Y.6
  • 5
    • 84870747517 scopus 로고    scopus 로고
    • Efficacy and safety of meropenem/clavulanate added to linezolid containing regimens in the treatment of M/XDR-TB
    • De Lorenzo S., Alffenaar J.W., Sotgiu G., Centis R., D'Ambrosio L., Tiberi S., et al. Efficacy and safety of meropenem/clavulanate added to linezolid containing regimens in the treatment of M/XDR-TB. Eur Respir J 2013, 41:1386-1392.
    • (2013) Eur Respir J , vol.41 , pp. 1386-1392
    • De Lorenzo, S.1    Alffenaar, J.W.2    Sotgiu, G.3    Centis, R.4    D'Ambrosio, L.5    Tiberi, S.6
  • 6
    • 84872419352 scopus 로고    scopus 로고
    • Is there a place for ß-lactams in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin/clavulanate
    • Gonzalo X., Drobniewski F. Is there a place for ß-lactams in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin/clavulanate. J Antimicrob Chemother 2013, 68:366-369.
    • (2013) J Antimicrob Chemother , vol.68 , pp. 366-369
    • Gonzalo, X.1    Drobniewski, F.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.